• Explore /
  • Poster
  • / Post radical prostatectomy (RP) PSA outcomes following 6 versus 18 months of perioperative androgen receptor signaling inhibitors (ARSI) in men with localized high-risk prostate cancer: Results of Part 2 of a randomized phase 2 trial.

Post radical prostatectomy (RP) PSA outcomes following 6 versus 18 months of perioperative androgen receptor signaling inhibitors (ARSI) in men with localized high-risk prostate cancer: Results of Part 2 of a randomized phase 2 trial.

Abstract Poster

Authors

null

Rana R. McKay

University of California, San Diego, La Jolla, CA

Rana R. McKay , Wanling Xie , Xiaoyu Yang , Andres Acosta , Dana E. Rathkopf , Vincent Paul Laudone , Glenn Bubley , David Johnson Einstein , Peter Chang , Andrew Wagner , Christopher J. Kane , Mark A. Preston , Kerry L. Kilbridge , Steven Lee Chang , Atish Dipankar Choudhury , Mark Pomerantz , Quoc-Dien Trinh , Adam S. Kibel , Mary-Ellen Taplin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT02903368

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 326)

DOI

10.1200/JCO.2024.42.4_suppl.326

Abstract #

326

Poster Bd #

N17

Abstract Disclosures

Similar Posters

First Author: Rana R. McKay

First Author: Robert B. Montgomery

First Author: John Nikitas

First Author: Rana R. McKay